Literature DB >> 2409614

Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis.

D Jenne, F Hugo, S Bhakdi.   

Abstract

Complement S-protein is known to function as an inhibitor of the terminal complement sequence (Bhakdi, S. and Tranum-Jensen, J., Biochim. Biophys. Acta 737, 343, 1983). We here report that the S-protein may also play a functional role in haemostasis. Electro-immunoassays performed with the use of poly- and monoclonal antibodies to the protein revealed that it binds to thrombin-anti-thrombin III (T X AT-III) to form stable S X T X AT-III complexes. These complexes form naturally during blood coagulation. They have been identified in human serum and have also been generated in vitro with the respective purified proteins. Formation of the complexes is paralleled by a net protection of thrombin towards the inactivating effects of AT-III, demonstrable in functional assays using a synthetic polypeptide or fibrinogen as substrates for the protease. S-protein may thus exert a promoting effect on blood coagulation and could emerge as a novel component of the blood coagulation system in the future.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409614     DOI: 10.1016/0049-3848(85)90138-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  S protein binds to serum-treated agarose beads independently of complement activation and the formation of the terminal complement complex on the beads.

Authors:  G Hetland; P Garred; H B Pettersen; T E Mollnes; E Johnson
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

4.  Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Histochemistry       Date:  1987

5.  Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue.

Authors:  J T Reilly; J R Nash
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

6.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

Authors:  J Bariety; N Hinglais; S Bhakdi; C Mandet; M Rouchon; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.

Authors:  K T Preissner; L Zwicker; G Müller-Berghaus
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

Review 8.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

9.  Vitronectin binds to activated human platelets and plays a role in platelet aggregation.

Authors:  E Asch; E Podack
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

10.  Alterations in extracellular matrix components and integrins in patients with preeclamptic nephropathy.

Authors:  H Shiiki; T Nishino; H Uyama; T Kimura; K Nishimoto; T Hashimoto; Y Fujii; K Dohi
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.